Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | chromobox homolog 1 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 1 | 1 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.838 | 0.8223 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.838 | 0.8223 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.838 | 0.8223 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.838 | 0.8223 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.838 | 0.838 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0047 | 0.216 | 0.7399 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.4925 | 0.4925 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.838 | 0.838 |
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 1 | 1 |
Brugia malayi | chromobox protein homolog 3 | 0.0047 | 0.216 | 0.1398 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.838 | 0.8223 |
Schistosoma mansoni | chromobox protein | 0.0084 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.4925 | 0.4432 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.216 | 0.216 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.838 | 0.838 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.838 | 0.8223 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0051 | 0.292 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.4925 | 0.4432 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.292 | 0.0969 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0084 | 1 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.292 | 0.0969 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0886 | 0.0886 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.838 | 0.8223 |
Schistosoma mansoni | chromobox protein | 0.0084 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.4925 | 0.4925 |
Brugia malayi | RNA binding protein | 0.0076 | 0.838 | 0.8223 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.9185 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.